Fitterfly, a leading health-tech company specializing in digital therapeutics (DTx), has released insightful data from the analysis of approximately 16,000 digital interactions involving individuals with pre-diabetes and diabetes. Conducted over a year using the platform’s diabetes
Recent Posts
- Beaufond PLC Eyes Dutch Pharma Alliance to Drive Oncology & Anti‑Malarial API Growth
- Trusted by His Tribe, Distrusted by the Nation: The Trump Paradox
- Iran War Sparks Pharma Shockwaves: India Faces $500 Million Export Hit
- The $100 Barrel: How a New Supreme Leader and a Closed Strait Are Redrawing the Global Power Map
- Trump’s Reign Of Chaos: Is He A Threat To World Peace?










